The University of Alberta is a Canadian leader in metabolomics research. Staff at NINT laboratories have been studying chemical processes involving metabolites for nearly a decade and continue to make great progress.
Through metabolic profiling, we are able to gain an instantaneous snapshot of the physiology of specific cells. Metabolites can:
- signal minute mutations in genes or proteins
- monitor or measure physiological changes occurring as a result of small changes in the environment, and
- report drug-related allergies.
The importance of metabolomics rests in its role as canary of the genome with a potentially significant impact on the diagnosis, treatment, prevention and monitoring of genetic, environmental or infectious diseases.
Metabolomics is pertinent to numerous Canadian companies across industrial sectors that need to understand the interplay between biologically derived organic chemicals. There is tremendous potential for advances in pharmacology, pre-clinical drug trials, toxicology, transplant monitoring, newborn screening and clinical chemistry.
We are on the cusp of capturing significant market share in this emerging field. Our pre-eminent research coupled with the presence of several multinationals means that Canada is ideally positioned for success.
Potential customers for metabolomics-based sensing systems include:
- major pharmaceutical companies,
- contract research organizations,
- veterinary and petrochemical industries,
- local and regional startup companies focused in metabolomics,
- major analytical firms and government departments and agencies.
NINT Researchers in Nanoscale Electronics
- Prasanna Bhomkar
- Ken Bosnick
- Jie Chen
- Rongbing Du
- Sergey Gusarov
- Jed Harrison
- Wayne Hiebert
- Alexander Kobryn
- Andriy Kovalenko
- Mark McDermott
- Larry Unsworth
- David Wishart
- Michael Woodside
For more information about our Metabolomics Sensor Systems Program, please contact:
Dr. Wayne Hiebert